Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Cytarabine Injection(For Intravenous or Subcutaneous Use)
Medication labelWhy this: Advisory · dailymed-prescription
Cytarabine Injection in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of Cytarabine Injection is indicated in the prophylaxis and treatment of meningeal leukemia.
- generic_name
- cytarabine
- product_names
- Cytarabine
- ndc
- 71288-168, 71288-168-50
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en